Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

Drug Topics: Sodium Bicarbonate Injections Recalled

Tuesday, June 20, 2017   (0 Comments)
Posted by: Dagmar Anderson
Share |

 

June 19, 2017 - Drug Topics

 

"Hospira Inc., a Pfizer company, announced that it is voluntarily recalling many lots of sodium bicarbonate injectables.

The recall comes in the middle of a severe nationwide sodium bicarbonate shortage. Companies are scrambling to come up with new supplies of the vital drug because of increased demand, but new product is only slowly trickling into the market."

 

“Patient harm, as a result from limited-to-no-access of a drug shortage product, can be remedied if FDA understands that access to compounded preparations goes much farther than the brick and mortar of a pharmacy,” said Baylor Rice, RPh, FIACP, President of IACP. “Prescribers, nurses, and other health-care entities require that compounded preparations need to be available for immediate use in emergency situations. The only way to meet this requirement is for the practitioner to house a small supply of the product in the practitioner’s office.”

A new bill introduced in Congress last week, HR 2871, could open up patient access to the drugs. 

 

Click here to read entire article.


Association Management Software Powered by YourMembership  ::  Legal